VANI vs. RCEL, SNWV, NVRO, NYXH, ELMD, PDEX, DRTS, LUNG, INGN, and TLSI
Should you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include AVITA Medical (RCEL), SANUWAVE Health (SNWV), Nevro (NVRO), Nyxoah (NYXH), Electromed (ELMD), Pro-Dex (PDEX), Alpha Tau Medical (DRTS), Pulmonx (LUNG), Inogen (INGN), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry.
Vivani Medical vs.
AVITA Medical (NASDAQ:RCEL) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, community ranking, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.
AVITA Medical presently has a consensus price target of $17.25, suggesting a potential upside of 78.02%. Vivani Medical has a consensus price target of $4.00, suggesting a potential upside of 288.35%. Given Vivani Medical's stronger consensus rating and higher possible upside, analysts clearly believe Vivani Medical is more favorable than AVITA Medical.
27.7% of AVITA Medical shares are owned by institutional investors. Comparatively, 6.8% of Vivani Medical shares are owned by institutional investors. 1.8% of AVITA Medical shares are owned by insiders. Comparatively, 44.3% of Vivani Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
In the previous week, Vivani Medical had 1 more articles in the media than AVITA Medical. MarketBeat recorded 2 mentions for Vivani Medical and 1 mentions for AVITA Medical. AVITA Medical's average media sentiment score of 1.89 beat Vivani Medical's score of 1.44 indicating that AVITA Medical is being referred to more favorably in the media.
AVITA Medical has a beta of 1.6, indicating that its share price is 60% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 2.76, indicating that its share price is 176% more volatile than the S&P 500.
Vivani Medical has lower revenue, but higher earnings than AVITA Medical. AVITA Medical is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks.
AVITA Medical received 77 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 70.34% of users gave AVITA Medical an outperform vote.
Vivani Medical has a net margin of 0.00% compared to AVITA Medical's net margin of -96.26%. Vivani Medical's return on equity of -102.42% beat AVITA Medical's return on equity.
Summary
Vivani Medical beats AVITA Medical on 12 of the 17 factors compared between the two stocks.
Get Vivani Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vivani Medical Competitors List
Related Companies and Tools
This page (NASDAQ:VANI) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy VANI Stock Free VANI Stock Alerts